Molecular Partners (MLLCF) News Today $5.89 0.00 (0.00%) (As of 09/18/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period Molecular Partners AG (MLLCF)August 10, 2024 | nz.finance.yahoo.comWarner Bros. Discovery Partners With NYLFF, LALIFF to Fund Latino Content CreatorsJuly 26, 2024 | msn.comThe ‘Platonic Life Partners’ Raising a Baby in a Flatbush DuplexApril 30, 2024 | msn.comECOPRO BM has taken a license from CAMX POWER to the latest GEMX® platform of cathode active material for lithium-ion batteriesApril 30, 2024 | finance.yahoo.comIntermediate Capital Group snaps up leading legal business information provider for £650mApril 27, 2024 | msn.comMolecular Partners Announces All Board Proposals Approved at the Annual General MeetingApril 17, 2024 | finance.yahoo.comMolecular Partners GAAP EPS of -$1.89 beats by $0.14, revenue of $7.0M beats by $1.93MMarch 14, 2024 | msn.comExpert Systems Expands Partnership with Eilean Therapeutics and Joins Its Best-in-Class PTPN2 Inhibitor ProgramMarch 12, 2024 | finance.yahoo.comMolecular Partners Gets Investor Class Action TossedMarch 1, 2024 | marketwatch.comMolecular Partners AG (MOLN)February 9, 2024 | investing.comBuy Rating Affirmed for 4D Molecular Therapeutics on Promising Wet AMD Treatment Trial ResultsFebruary 7, 2024 | markets.businessinsider.comMolecular Partners AG ADR (MOLN)February 6, 2024 | investing.comScientists found a major clue why 4 of 5 autoimmune patients are womenFebruary 4, 2024 | msn.comPenn names new chief innovation officer, aiming to expand a multibillion-dollar windfall from faculty researchFebruary 4, 2024 | msn.comMolecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin TherapiesJanuary 5, 2024 | finance.yahoo.comRetail investors account for 43% of Molecular Partners AG's (VTX:MOLN) ownership, while hedge funds account for 33%December 22, 2023 | finance.yahoo.comMolecular Partners to Present at 42nd Annual J.P. Morgan Healthcare Conference and Swiss Investor ConferencesDecember 14, 2023 | finance.yahoo.comMolecular Partners AG - ADR (MOLN) Price Target Increased by 12.87% to 10.29November 27, 2023 | msn.comMolecular Partners (MLLCF) Price Target Increased by 21.13% to 10.71November 27, 2023 | msn.comMolecular Partners AG (MOLN.SW)November 14, 2023 | sg.finance.yahoo.comMolecular Partners to Present on DARPin Oncology Innovations at Protein & Antibody Engineering Summit Europe (PEGS)November 14, 2023 | finance.yahoo.comWe're Keeping An Eye On Molecular Partners' (VTX:MOLN) Cash Burn RateNovember 9, 2023 | finance.yahoo.comBuy Rating for 4D Molecular Therapeutics: An Analysis of Potential Growth and Future ProspectsNovember 6, 2023 | markets.businessinsider.comMolecular Partners Presents Updated Positive Data from Ongoing Phase 1 Trial of MP0317 (FAP X CD40) Monotherapy in Patients with Advanced Solid Tumors at the 2023 SITC Annual MeetingNovember 3, 2023 | finance.yahoo.comCompanion Animal Diagnostics Market Size to Hit 9.1% CAGR, Globally, by 2030 - Exclusive Report by The Insight PartnersNovember 3, 2023 | finance.yahoo.comMolecular Partners Interim Management Statement Q3 2023: Continued Validation Seen Across the DARPin PortfolioOctober 26, 2023 | finance.yahoo.comShareholders in Molecular Partners (VTX:MOLN) are in the red if they invested five years agoOctober 5, 2023 | finance.yahoo.comMolecular Partners Presents New Data on its Radio DARPin Therapy (RDT) Platform at the EANM 2023 Annual MeetingSeptember 13, 2023 | finance.yahoo.comMolecular Partners (MLLCF) Price Target Decreased by 30.37% to 8.84September 3, 2023 | msn.comChardan Capital Reiterates 4D Molecular Therapeutics (FDMT) Buy RecommendationAugust 11, 2023 | msn.comOut of the lab and into the hospitalAugust 4, 2023 | bizjournals.comMolecular Partners Ag (NASDAQ: MOLN)July 19, 2023 | fool.comChardan Capital Initiates Coverage of 4D Molecular Therapeutics (FDMT) with Buy RecommendationJuly 5, 2023 | msn.comMicrobix QAPs Supporting HPV Testing Across The NetherlandsJuly 5, 2023 | finance.yahoo.comREALM IDx Launches REALM Pharma Services to Improve Drug Development and ResearchJune 1, 2023 | finance.yahoo.comM&A wrap: Diagnostic company merges with ultra-fast PCR testing platform, plus more dealsMay 19, 2023 | bizjournals.comMolecular Partners to Participate in RBC Capital 2023 Global Healthcare ConferenceMay 16, 2023 | finance.yahoo.comInstitutional investors have a lot riding on 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) with 44% ownershipMay 13, 2023 | finance.yahoo.comGetting In Cheap On Molecular Partners AG (VTX:MOLN) Is UnlikelyMay 13, 2023 | finance.yahoo.comVirpax Pharmaceuticals Reports 2023 First Quarter Results and Recent DevelopmentsMay 12, 2023 | businesswire.comInterim Management Statement Q1 2023 of Molecular Partners: Well Capitalized to Pursue Highly Differentiated DARPin Portfolio StrategyMay 11, 2023 | finance.yahoo.comMainz Biomed Announces Addition of Eurofins GeLaMed to its Growing Network of Lab PartnersMay 3, 2023 | technews.tmcnet.comInvestors in Molecular Partners (VTX:MOLN) have unfortunately lost 79% over the last five yearsApril 18, 2023 | finance.yahoo.comThe SPHERES Registry of Patients with NMOSD Reaches Enrollment Milestone of 200 PatientsApril 12, 2023 | markets.businessinsider.comChardan Capital Downgrades Applied Molecular Transport (AMTI)March 29, 2023 | msn.comBiotech Innovator Leen Kawas On How Biomarkers Integrate with AI and Machine Learning to Solve Complex Healthcare ProblemsMarch 21, 2023 | tmcnet.comMolecular Partners Publishes Invitation to Annual General Meeting 2023March 13, 2023 | finance.yahoo.comMolecular Partners Full Year 2022 Earnings: Beats ExpectationsMarch 11, 2023 | finance.yahoo.comExploring the Impregnated Activated Carbon Market: Progresses for Huge Profits during 2023-2028March 7, 2023 | marketwatch.comMolecular Partners to Hold Conference Call to Discuss Fourth Quarter and Full Year 2022 Results and Present at the 43rd Annual Cowen Health Care ConferenceMarch 2, 2023 | finance.yahoo.com Get Molecular Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for MLLCF and its competitors with MarketBeat's FREE daily newsletter. Email Address War on Elon Escalates… (Ad)Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. Click here to learn how you can benefit from its widespread distribution. MLLCF Media Mentions By Week MLLCF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MLLCF News Sentiment▼0.000.68▲Average Medical News Sentiment MLLCF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MLLCF Articles This Week▼00▲MLLCF Articles Average Week Get Molecular Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for MLLCF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News Today ALK-Abelló A/S News Today Alpha Tau Medical News Today Arno Therapeutics News Today Ascentage Pharma Group International News Today Ascletis Pharma News Today Awakn Life Sciences News Today AXIM Biotechnologies News Today BerGenBio ASA News Today BriaCell Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MLLCF) was last updated on 9/18/2024 by MarketBeat.com Staff From Our PartnersChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredCrypto ‘Banana Zone’ Incoming…What if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Partners AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Molecular Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
